3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
1
Classical hematology
1
Conditions
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
fludarabine phosphate
15
Whole-Body Irradiation
9
Peripheral Blood Stem Cell Transplantation
8
Mycophenolic Acid
8
Cyclosporine
8
Cyclophosphamide
7
Tacrolimus
5
Filgrastim
5
Cytarabine
5
Carboplatin
4
Azacitidine
4
olaparib
3
Thiotepa
3
Lenalidomide
3
Etoposide
3
Bortezomib
3
Biopsy
3
Antilymphocyte Serum
3
venetoclax
2
tipifarnib
2
sargramostim
2
peginesatide
2
laromustine
2
hematide
2
enasidenib
2
alvocidib
2
aldesleukin
2
Vorinostat
2
Tretinoin
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sertraline
×
Classical hematology
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled